Ovid Therapeutics (OVID) Shares Outstanding (Diluted) (2020 - 2026)
Powered by 
Analysis
Ovid Therapeutics (OVID) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 5.70 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 1.23 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | 210.89 Mn |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 115.80 Mn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 208.22 Mn |
| 10 | Ovid Therapeutics | 517.32 Mn | 400.10 Mn | - | 197.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 197.45 Mn |
| Mar 31, 2026 | 136.17 Mn |
| Dec 31, 2025 | 73.74 Mn |
| Sep 30, 2025 | 71.11 Mn |
| Jun 30, 2025 | 71.11 Mn |
| Mar 31, 2025 | 71.05 Mn |
| Dec 31, 2024 | 70.91 Mn |
| Sep 30, 2024 | 70.98 Mn |
| Jun 30, 2024 | 71.20 Mn |
| Mar 31, 2024 | 70.72 Mn |
| Dec 31, 2023 | 70.58 Mn |
| Sep 30, 2023 | 70.62 Mn |
| Jun 30, 2023 | 70.53 Mn |
| Mar 31, 2023 | 70.49 Mn |
| Dec 31, 2022 | 70.42 Mn |
| Sep 30, 2022 | 70.43 Mn |
| Jun 30, 2022 | 70.39 Mn |
| Mar 31, 2022 | 70.35 Mn |
| Dec 31, 2021 | 68.07 Mn |
| Sep 30, 2021 | 67.93 Mn |